DRUG STUDY

STUDENT’S NAME: CRISTINE ANNE A. DELA CRUZ

YEAR & SECTION: BN3G
GROUP 1
DRUG NAME DOSAGE/FREQUENCY/ MECHANISM OF ACTION INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING CONSIDERATION
ROUTE

GENERIC NAME: DOSAGE: 40g Gastric acid-pump inhibitor: Indicated for:
Suppresses gastric acid
Omeprazole  Short-term treatment of
secretion by specific
FREQUENCY: OD activeduodenal ulcer;
inhibition of the hydrogen-
First-line therapy in
BRAND NAME: potassium ATPase enzyme
treatment of heartburn or
Losec (CAN) ROUTE: IVTT system at the secretory
symptoms of
surface of the gastric
gastroesophageal reflux
parietal cells; blocks the
DRUG CLASSIFICATION: disease (GERD);
final step of acid production.
Antisecretory drug  Short-term treatment of
active benign gastric ulcer;
Proton pump inhibitor
 GERD, severe erosive
esophagitis, poorly
responsive symptomatic
GERD;
 Long-term therapy:
Treatment of pathologic
hypersecretory conditions
(Zollinger-Ellison
syndrome, multiple
adenomas, systemic
mastocytosis);
 Eradication of H. pylori
with amoxicillin or
metronidazole and
clarithromycin;
Contraindicated with CNS: Headache, dizziness, C: Antisecretory drug;
hypersensitivity to asthenia, vertigo, insomnia,
Proton pump inhibitor
omeprazole or its apathy, anxiety,
H: IVTT
components; paresthesias, dream
E: decrease gastric acid
Use cautiously with abnormalities
secretion
pregnancy, Dermatologic: Rash,
C: Take the drug before
lactation. inflammation, urticaria,
meals.
pruritus, alopecia, dry skin
Report severe headache,
GI: Diarrhea, abdominal
worsening of
pain, nausea, vomiting,
symptoms, fever, chills.
constipation, dry mouth,
K: Swallow the
tongue atrophy
capsules whole; do not
Respiratory: URI symptoms,
chew, open, or crush
cough, epistaxis
them.
Other: Cancer in
preclinical studies,
back pain, fever